Sandra Schmitz

PDGFR Signaling Blockade in Marrow Stroma Impairs Lung Cancer Bone Metastasis

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases

Head and neck squamous cell carcinoma

Clinical update on head and neck cancer: molecular biology and ongoing challenges

Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation

Cancer to bone: a fatal attraction

The insulin and insulin-like growth factor receptor family in neoplasia: an update

Molecular Aspects of Head and Neck Cancer Therapy

Nasopharyngeal carcinoma

Recent advances in bone tissue engineering scaffolds

Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer

Enter the Matrix: Factorization Uncovers Knowledge from Omics

Sentinel node biopsy in early oral squamous cell carcinomas: A 10‐year experience

Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance

Advances in the management of squamous cell carcinoma of the head and neck

Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)

Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01

Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer